Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Selumetinib sulfate

SKU: orb1908987

Description

Selumetinib sulfate (AZD6244 sulfate) is a potent, selective, and orally bioavailable MEK1/2 inhibitor. It is used in preclinical and clinical research for neurofibromatosis type 1, particularly for studying symptomatic, inoperable plexiform neurofibromas, based on in vitro and in vivo evidence.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number943332-08-9
MW555.76
Purity99.65% (May vary between batches)
FormulaC17H17BrClFN4O7S
SMILESO=C(NOCCO)C1=CC2=C(N=CN2C)C(F)=C1NC3=CC=C(Br)C=C3Cl.O=S(=O)(O)O
TargetMEK,Apoptosis
SolubilityDMSO:40 mg/mL (71.97 mM);H2O:< 1 mg/mL (insoluble);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.6 mM)

Bioactivity

Target IC50
purified MEK:12 nM
In Vivo
In in vivo experiments, oral administration of 50 and 100 mg/kg Selumetinib sulfate dose-dependently reduced the growth rate of 4-1318 xenograft tumors; it also significantly inhibited the growth of 5-1318, 2-1318, 26-1004, and 29-1104 xenograft tumors at the 50 mg/kg dose. Oral administration of 10, 25, 50, or 100 mg/kg Selumetinib sulfate also inhibited ERK1/2 phosphorylation and reduced HT-29 xenograft tumor growth in nude mice. Meanwhile, tumor regression was observed in the BxPC3 xenograft model.
In Vitro
Selumetinib sulfate (AZD6244) is a potent MEK inhibitor with an IC50 of 12 nM for purified MEK.Selumetinib sulfate is able to inhibit ERK1/2 phosphorylation in a variety of cancer cell lines with IC50s as low as 8 nM, both at basal and induced levels. In primary 2-1318 cells, Selumetinib sulfate induces growth arrest and apoptosis associated with ERK inactivation, resulting in reduced primary DNA synthesis and reduced cell viability over time and dose. In H-441 and H-1437 cells, Selumetinib sulfate (1 μM) exhibits antiproliferative effects by blocking the G0/G1 phase. In addition, Selumetinib sulfate inhibited the growth of various cell lines harboring B-Raf and Ras mutations, but had no significant effect on normal fibroblast cell lines.

Storage & Handling

Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

ARRY-142886 sulfate, AZD6244 sulfate
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Selumetinib sulfate (orb1908987)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

25 mg
$ 80.00
50 mg
$ 100.00
1 ml x 10 mM (in DMSO)
$ 110.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry